These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21236235)

  • 41. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting.
    Carvajal A; Ortega PG; Sáinz M; Velasco V; Salado I; Arias LH; Eiros JM; Rubio AP; Castrodeza J
    Vaccine; 2011 Jan; 29(3):519-22. PubMed ID: 21112311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.
    Cheong HJ; Song JY; Heo JY; Noh JY; Choi WS; Park DW; Wie SH; Kim WJ
    Vaccine; 2011 Jan; 29(3):523-7. PubMed ID: 21055502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
    N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The safety and immunogenicity of the vaccines against pandemic (H1N1) 2009 influenza].
    Grotto I; Engelhard D
    Harefuah; 2009 Dec; 148(12):799-803, 857. PubMed ID: 20088428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan.
    Igari H; Segawa S; Watanabe A; Suzuki A; Watanabe M; Sakurai T; Kuroda F; Watanabe M; Tatsumi K; Nakayama M; Nakayama T; Suzuki K; Sato T
    Microbiol Immunol; 2010 Oct; 54(10):618-24. PubMed ID: 21118299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pandemic influenza vaccination: will the health care system take its own medicine?
    Ferguson CD; Ferguson TE; Golledge J; McBride WJ
    Aust J Rural Health; 2010 Aug; 18(4):137-42. PubMed ID: 20690908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
    Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
    Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    Kung HC; Huang KC; Kao TM; Lee YC; Chang FY; Wang NC; Liu YC; Lee WS; Liu HJ; Chen CI; Chen CH; Huang LM; Hsieh SM
    Vaccine; 2010 Oct; 28(45):7337-43. PubMed ID: 20817013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Issues in vaccination against influenza A in Spain].
    Bayas Rodríguez JM; García-Basteiro AL; Mena Pinilla G
    Arch Bronconeumol; 2010 Mar; 46 Suppl 2():32-8. PubMed ID: 20353857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
    Mackay HJ; McGee J; Villa D; Gubbay JB; Tinker LM; Shi L; Kuruvilla J; Wang L; MacAlpine K; Oza AM
    J Clin Virol; 2011 Mar; 50(3):212-6. PubMed ID: 21168361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
    Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
    N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice.
    Opstelten W; van Essen GA; Heijnen ML; Ballieux MJ; Goudswaard AN
    Vaccine; 2010 Aug; 28(38):6164-8. PubMed ID: 20659516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    van Balveren-Slingerland L; Kant A; Härmark L
    Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367
    [No Abstract]   [Full Text] [Related]  

  • 60. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
    Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
    Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.